Author:
Garza Maryam Y.,Williams Tremaine,Myneni Sahiti,Fenton Susan H.,Ounpraseuth Songthip,Hu Zhuopei,Lee Jeannette,Snowden Jessica,Zozus Meredith N.,Walden Anita C.,Simon Alan E.,McClaskey Barbara,Sanders Sarah G.,Beauman Sandra S.,Ford Sara R.,Malloch Lacy,Wilson Amy,Devlin Lori A.,Young Leslie W.
Abstract
Abstract
Background
Studies have shown that data collection by medical record abstraction (MRA) is a significant source of error in clinical research studies relying on secondary use data. Yet, the quality of data collected using MRA is seldom assessed. We employed a novel, theory-based framework for data quality assurance and quality control of MRA. The objective of this work is to determine the potential impact of formalized MRA training and continuous quality control (QC) processes on data quality over time.
Methods
We conducted a retrospective analysis of QC data collected during a cross-sectional medical record review of mother-infant dyads with Neonatal Opioid Withdrawal Syndrome. A confidence interval approach was used to calculate crude (Wald’s method) and adjusted (generalized estimating equation) error rates over time. We calculated error rates using the number of errors divided by total fields (“all-field” error rate) and populated fields (“populated-field” error rate) as the denominators, to provide both an optimistic and a conservative measurement, respectively.
Results
On average, the ACT NOW CE Study maintained an error rate between 1% (optimistic) and 3% (conservative). Additionally, we observed a decrease of 0.51 percentage points with each additional QC Event conducted.
Conclusions
Formalized MRA training and continuous QC resulted in lower error rates than have been found in previous literature and a decrease in error rates over time. This study newly demonstrates the importance of continuous process controls for MRA within the context of a multi-site clinical research study.
Funder
National Center for Advancing Translational Sciences
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Reference20 articles.
1. Kellar E, Bornstein SM, Caban A, Celingant C, Crouthamel M, Johnson C, et al. Optimizing the use of electronic data sources in clinical trials: the landscape, part 1. Ther Innov Regul Sci. 2016;50(6):682–96. https://doi.org/10.1177/2168479016670689.
2. Nahm M. Measuring data quality. In: Good Clinical Data Management Practices (GCDMP) (Version 2000 - present). Society for Clinical Data Management 2012. Available from: https://www.scdm.org/gcdmp. Accessed Aug 2020.
3. Zozus M, Pieper C, Johnson C, Johnson TR, Franklin A, Smith J, et al. Factors affecting accuracy of data abstracted from medical records. PLoS ONE. 2015;10(10):e0138649. https://doi.org/10.1371/journal.pone.0138649.
4. Nahm ML, Pieper CF, Cunningham MM. Quantifying data quality for clinical trials using electronic data capture. PLoS ONE. 2008;3(8):e3049. https://doi.org/10.1371/journal.pone.0003049.
5. Nahm M, Nguyen VD, Razzouk E, Zhu M, Zhang J. Distributed cognition artifacts on clinical research data collection forms. Summit Transl Bioinform. 2010;1(2010):36–40.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献